We're ready for #SCCT2024! Come meet us in DC, message us to make an appointment in advance! Find us: 💻 Thursday July 18 | Elucid is proud to be a sponsor of the AI/ML Interactive Workshop. Join us for a great engaging all-day program (see SCCT page for more info). 💡 Friday July 19 7 AM | Kick off the weekend at our breakfast symposium featuring Drs Matthew Budoff and Mark Rabbat MD,FSCCT,FACC,FAHA. Come by to hear more about QCPA in clinical care and the value of histology-based #plaque quantitation (and for a great breakfast to fuel you through the morning!) 🤝 Friday and Saturday all day | Visit us at booth 301 to meet the Elucid team, take a peek at our latest technology, and learn how we can fit seamlessly into your program's workflow. See how histology can make a difference. #SeeBeyondtheLumen #YesCCT #CTfirst
Elucid
Medical Equipment Manufacturing
Boston, Massachusetts 5,040 followers
Bringing Imaging to Life
About us
Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid's CTA analysis equips physicians with critical information designed to enable precision medicine. Elucid is the first non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall. Elucid's unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs.
- Website
-
https://elucid.com
External link for Elucid
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 2013
- Specialties
- cardiovascular, plaque characterization, FFRct, CCTA, Heart Disease, CT Angiography, CCT, Stroke, and Heart Attck
Locations
-
Primary
Get directions
399 Boylston St
Suite 400
Boston, Massachusetts 02116, US
Employees at Elucid
Updates
-
We're #hiring a new Clinical Validation Engineer in Boston, Massachusetts. Apply today or share this post with your network.
-
Elucid reposted this
The #SCCT2024 countdown has begun! Get ready for the amazing experiences, networking opportunities, & inspiring innovations that await – join us next week in Washington, DC! Save your spot today & be sure to mark your calendar for July 18-21. https://ow.ly/mBrb50SxagA
-
-
Exciting news at Elucid! 📍 Read here: https://lnkd.in/gFzWdEvA We've moved our HQ office to Boylston Street in beautiful Back Bay! While we aren't too far from where we were previously, we've greatly expanded in office space to accommodate our growing team, and upgraded our facilities to foster a more collaborative and inspiring environment.
-
-
#SCCT2024 is a month away! Start SCCT with us at our breakfast symposium on Friday July 19, 7 AM ET, featuring Drs Matthew Budoff and Mark Rabbat MD,FSCCT,FACC,FAHA as we discuss the impact of advanced plaque analysis in #YesCCT programs. We will also be at booth #301 on Friday and Saturday July 19-20 - stop by and hear what's coming! Thank you Society of Cardiovascular Computed Tomography
-
-
This Friday! See you at University of Chicago's Annual #Stroke Symposium at the David Rubenstein Forum!
-
-
Thank you Healthcare IT Today for sharing our perspective on #AI in #Healthcare and how our specific technology can have a significant impact in cardiovascular care. https://lnkd.in/g2aeGb2G
-
Blake Richards will be speaking at the upcoming New York City Health Innovation Week on Monday May 6. Tune in to hear his perspective on AI's role in the health system. Thank you HITLAB for the invitation; excited to share on our experience developing next generation technology to aid clinicians and their patients! #healthtech #ai #healthinnovation #nychiw Learn more here: https://lnkd.in/eJf7buPU
-
-
Congratulations to CVPath Institute, Inc. Founder and President Dr. Renu Virmani who was recently awarded the 2024 Arthur S. Agatston Cardiovascular Disease Prevention Award by Society of Cardiovascular Computed Tomography. Her work has revolutionized the understanding of coronary atherosclerotic plaques and their role in sudden coronary death, and has certainly been of incredible value in establishing some of the core groundwork at Elucid. Well deserved! Read more here: https://lnkd.in/dhJSFuha #YesCCT #CoronaryArteryDisease #Plaque #HeartAttackPrevention #EndCVD #Atherosclerosis
SCCT honors Dr. Renu Virmani with 2024 Arthur S. Agatston Award - Society of Cardiovascular Computed Tomography
scct.org